Eupraxia Pharmaceuticals EPRX
NASDAQ EPRX
$7.24 -0.59 (-7.54%)
At close: Oct 2, 2026 · 4:00 PM EDT

Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (2023 - 2024)

Updated

Eupraxia Pharmaceuticals' Interest Coverage Ratio was -54968.43 in the quarter ended Dec 31, 2024.

Analysis

Eupraxia Pharmaceuticals (EPRX) Interest Coverage Ratio (2023 - 2024) Analysis & Trends

For the year ended Dec 31, 2024, Interest Coverage Ratio at Eupraxia Pharmaceuticals came in at -43.65.

  • In earlier years, Interest Coverage Ratio was -25.72 in the year ended Dec 31, 2023 and -20.32 in the year ended Dec 31, 2022.
  • Per Business Quant data, EPRX's Interest Coverage Ratio in the three quarters before the quarter ended Dec 31, 2024 was -13285.52 (quarter ended Sep 30, 2024), -22.53 (quarter ended Jun 30, 2024) and -20.16 (quarter ended Mar 31, 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 25.41
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn -
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 10.28
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 7.27
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 5.22
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -42.08
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 Eupraxia Pharmaceuticals 312.86 Mn 311.25 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -54,968.43
Sep 30, 2024 -13,285.52
Jun 30, 2024 -22.53
Mar 31, 2024 -20.16
Jun 30, 2023 -32.50
Mar 31, 2023 -14.57
API Access

Eupraxia Pharmaceuticals Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=EPRX&period=max&api_key=YOUR_API_KEY